Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations are in order to Professor Pawel Swietach, who will represent the Department in strategic decision-making for Oxford Cancer.

Oxford Cancer is a city-wide network and partnership between Oxford University and Oxford University Hospitals NHS Trust, established with funding from Cancer Research UK in recognition of the University's breakthrough research in cancer. Oxford Cancer coordinates collaboration across the city of Oxford to ensure rapid translation from scientific discovery to treatments for patients.

The Oxford Cancer Oversight Committee facilitates efforts across the University, comprising over 900 members from around 90 different Departments, Units, Institutes of the University, as well as the NHS Trust who invest over £55m each year into translational cancer research. Meeting twice a year, The Committee will advise and help in reaching the strategic objectives of the centre.

On his invitation to join The Committee, Professor Pawel Swietach said: "I am delighted to be a member of this committee. I am keen to highlight DPAG’s interests in the extensive network of cancer scientists at Oxford. DPAG can play an active role in new, multi-disciplinary programmes and to enable this, my priority is to look out for opportunities to pair the best scientists and state-of-the-art facilities across our city. DPAG has much potential in these endeavours as our expertise lies in systems biology. This integrative approach to understanding disease is important at a time when large volumes of data are collected, and must be assembled together into working models. I look forward to hearing from colleagues about how best to involve our department in University-wide activities."

Similar stories

Mootaz Salman set to target new treatments for stroke

The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations are in order for Professor Gero Miesenböck, who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.

Mootaz Salman receives prestigious science award from Iraq

Congratulations are in order for Dr Mootaz Salman, who has received the National Medal of Distinctive Scientific Achievement by the Government of Iraq.

Professor Denis Noble awarded the Lomonosov Gold Medal

The Russian Academy of Sciences has awarded its highest accolade, the Lomonosov Gold Medal, to Emeritus Professor Denis Noble CBE, FRS.

Professor Dame Frances Ashcroft awarded the Manpei Suzuki International Prize for Diabetes Research

The 2022 Manpei Suzuki International Prize for Diabetes Research recognises original and excellent achievements in diabetes research. Professor Ashcroft is the first women to win in the 15 years this prestigious Prize has been awarded.